Archive for the ‘biotech/medical’ category: Page 2005
Aug 18, 2018
Keystone Virus Makes First Known Jump From Mosquitoes To Humans
Posted by Genevieve Klien in category: biotech/medical
A 16-year-old Florida boy is the first person known to have become infected, researchers say. Symptoms in humans include a rash and mild fever.
Aug 18, 2018
The State of Brain-Machine Interfaces — Prof. Maryam Shanechi
Posted by Marcos Than Esponda in categories: biotech/medical, genetics, neuroscience
Maryam shanechi, university of southern california.
With recent technological advances, we can now record neural activity from the brain, and manipulate this activity with electrical or optogenetic stimulation in real time. These capabilities have brought the concept of brain-machine interfaces (BMI) closer to clinical viability than ever before. BMIs are systems that monitor and interact with the brain to restore lost function, treat neurological disorders, or enhance human performance.
Continue reading “The State of Brain-Machine Interfaces — Prof. Maryam Shanechi” »
Aug 18, 2018
A review and implications for aging research
Posted by Franco Cortese in categories: biotech/medical, life extension
The effects of donor age on organ transplants: A review and implications for aging research.
Despite the considerable amount of data available on the effect of donor age upon the outcomes of organ transplantation, these still represent an underutilized resource in aging research. In this review, we have compiled relevant studies that analyze the effect of donor age in graft and patient survival following liver, kidney, pancreas, heart, lung and cornea transplantation, with the aim of deriving insights into possible differential aging rates between the different organs. Overall, older donor age is associated with worse outcomes for all the organs studied. Nonetheless, the donor age from which the negative effects upon graft or patient survival starts to be significant varies between organs. In kidney transplantation, this age is within the third decade of life while the data for heart transplantation suggest a significant effect starting from donors over age 40. This threshold was less defined in liver transplantation where it ranges between 30 and 50 years. The results for the pancreas are also suggestive of a detrimental effect starting at a donor age of around 40, although these are mainly derived from simultaneous pancreas-kidney transplantation data. In lung transplantation, a clear effect was only seen for donors over 65, with negative effects of donor age upon transplantation outcomes likely beginning after age 50. Corneal transplants appear to be less affected by donor age as the majority of studies were unable to find any effect of donor age during the first few years posttransplantation. Overall, patterns of the effect of donor age in patient and graft survival were observed for several organ types and placed in the context of knowledge on aging.
Aug 18, 2018
Living in a culture dependant upon caffeine and lack of sleep, its important to remember that sleep offers an incredibly important biological function
Posted by Nicholi Avery in categories: biotech/medical, neuroscience
One night of sleep deprivation is tied to Alzheimer’s disease.
For the past few years researchers have shown that the brain flushes out neurotoxins during the period people are sleeping.
https://www.chronobiology.com/neurotoxins-and-sleep-what-you-need-to-know/
Aug 18, 2018
Do you want to join in the fight to end age-related disease?
Posted by Michael Greve in categories: biotech/medical, life extension
Together, Forever Healthy Foundation and SENS Research Foundation are now accepting research proposals that promise progress in regenerative medicine for the prevention and reversal of age-related disease. This Fellowship will take place at SRF’s research center in Mountain View, California.
For more information, please visit: http://sens.org/research/research-blog/forever-healthy-found…technology
Aug 18, 2018
What Causes Glaucoma? Scientists May Have Finally Figured It Out
Posted by Genevieve Klien in category: biotech/medical
Researchers say an autoimmune response may be behind the eye pressure and vision loss that sometimes precedes a glaucoma diagnosis.
Aug 17, 2018
The Dark Secret These Corporations Are Hiding From You
Posted by Michael Dodd in categories: biotech/medical, evolution, food, neuroscience
This is a must watch video. It tells a painful truth of our real world. It is worth the watch. Please pass this video along if you are so inclined.
Excerpt: You live in a world of drug dealers. Only the drugs can be bought legally, and are perfectly priced to prevent you from inquiring into other areas. Your society exhibits a wealth of negative side effects from these drugs. Yet the bulk of your population still continues to use our products, even after they’ve shown themselves to be harmful. You live in a population that continues to grow more restless, agitated, and depressed, in part from eating our goodies and treats. Treats that are called “superstimuli” as the stimulus it produces inside your brain vastly exceeds the natural stimuli humans received throughout evolution, from natural foods.
Continue reading “The Dark Secret These Corporations Are Hiding From You” »
Aug 17, 2018
Aubrey de Grey — We Will End Aging
Posted by Bill Kemp in categories: biotech/medical, life extension
Website ► http://sens.org
YouTube ► https://www.youtube.com/user/SENSFVideo
Facebook ► https://www.facebook.com/sensf
Twitter ► https://twitter.com/senstweet
“At SENS Research Foundation, we believe that a world free of age-related disease is possible. That’s why we’re funding work at universities across the world and at our own Research Center in Mountain View, CA.
Aug 17, 2018
Steven A. Garan — Silicon Valley’s Role in Fighting Aging
Posted by Steve Hill in categories: biotech/medical, life extension
Today, we would like to share the talk that Steven A. Garan gave at our recent conference in New York, Ending Age-Related Diseases: Investment Prospects & Advances in Research. The conference focused on bringing together the world of research and investment and bringing thought leaders, investors, the media, and the general public together.
Steven A. Garan is the Director of Bioinformatics at the Center for Research and Education on Aging (CREA) and a researcher at UC Berkeley National Laboratory. In his talk at Ending Age-Related Diseases, he discussed the impact of various present and future Silicon Valley technology breakthroughs on overcoming aging.
Continue reading “Steven A. Garan — Silicon Valley’s Role in Fighting Aging” »